Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-338-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline and EU method. GLP study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Reaction products of imine and acrylate
- Molecular formula:
- Not applicable. UVCB substance
- IUPAC Name:
- Reaction products of imine and acrylate
- Details on test material:
- - Physical state: amber, clear liquid
- Lot/batch No.: 3017/20495
- Storage condition of test material: in cool, airy places away from strong alkalies, acids, ignition sources, direct sunlight.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Germany
- Age at study initiation: One 10-week-old female was used in the sighting study. Four 11-week-old females were used in the main study.
- Weight at study initiation: One female weighing 200 g was used in the sighting study. Four females with the average body weight of 207 g were used in the main study.
- Fasting period before study: The animals will be starved for 18 hours prior to the administration of the test item.
- Housing: The rats will be kept in plastic cages with a wire bar lids and the following dimensions: (length x width x height) 58 x 37 x 21 cm. UV-sterilized wood shavings will be used as bedding.
- Diet (e.g. ad libitum): standard granulated fodder “Murigran", ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23 °C
- Humidity (%): 40 – 70%
- Air changes (per hr): 12 hours light – 12 hours dark
- Photoperiod (hrs dark / hrs light): about 16 times/hour
Administration / exposure
- Route of administration:
- other: oral: The test item at a single dose will be given to the stomach of the animal with the aid of a ball ended feeding needle affixed to the top of a syringe.
- Vehicle:
- water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: For all tested doses, the test item will be given in the form of an aqueous solution in a constant volume but at different concentrations. The volume of the aqueous solution given once to the animals will be equal to 0.5 mL/100 g b.w.
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 females per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The evaluation of a general condition of animals, i.e. the observation of all animals for morbidity and mortality will be conducted twice a day or once a day on days off. Detailed clinical observations taking place on the administration day (day 0) will be performed 10, 30 and 60 minutes after the administration and then at hourly intervals – up to the 5th hour after the administration. From the 1st to the 14th day of the observation period detailed clinical observations will be performed once a day. The observations will comprise: changes of the skin, hair, eyes and mucous membranes, respiratory system, circulatory system, autonomic and central nervous system, somatic activity and behavior.
Body weight of the animals will be determined individually for each animal directly before the administration of the test item (day 0) and then on the 7th and the 14th day.
- Necropsy of survivors performed: yes.
All rats which die spontaneously during the experiment will be subjected to a gross necropsy. The rats which survive the experiment will be killed after a 14-day observation period by the intraperitoneal administration of morbital at a dose of 200 mg/kg b.w. and subjected to a post mortem examination. A detailed gross examination of the external body surfaces, all apertures, cranial, thoracic and abdominal cavity with their content will be performed at necropsy.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived the period of the experiment.
- Clinical signs:
- Sighting study
Following a single administration of the test item at a dose of 2000 mg/kg b.w. to one animal used in the sighting study, one stated some signs of toxicity; however, they were visible only on the administration day.
Main study
Following a single administration of the test item at a dose of 2000 mg/kg b.w. to four animals used in the main study, one stated some signs of toxicity; however, they were visible only on the administration day. - Body weight:
- During the whole experiment all animals’ body weight increased.
- Gross pathology:
- The gross examination did not reveal any pathological changes in the animals.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 value was determined to be greater than 2000 mg/kg bw.
- Executive summary:
The acute oral toxicity study – fixed dose procedure will be conducted in compliance with the OECD Guideline for the Testing of Chemicals No 420 (2001): “Acute oral toxicity – fixed dose procedure” and EU Method B.1.BIS.: “Acute oral toxicity – fixed dose procedure”.
A group of five Sprague-Dawley female rats was exposed orally to a dose level of 2000 mg/kg bw. All animals survived the period of the experiment.
The oral LD50 value was determined to be greater than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.